Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Cibus Q1 Earnings Call Highlights
Cibus Reports First Quarter Financial Results and Provides Business Update
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call
Cibus Announces the Election of Thomas Urban to Board of Directors
Cibus, Inc. Investigated by the Portnoy Law Firm
Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus (CBUS) Reports Q4 Loss, Lags Revenue Estimates
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call
Cibus Partnering with The John Innes Centre for UK Government's Farming Innovation Programme Precision Breeding Initiative
Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America
Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council
Cibus, Inc. (CBUS) Q3 2025 Earnings Call Transcript
Cibus (CBUS) Reports Q3 Loss, Misses Revenue Estimates
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025
Cibus Announces the Election of Craig Wichner to Board of Directors
Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call
Cibus and AgVayā Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing
Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola
Cibus Announces the Election of Kimberly A. Box to Board of Directors
Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025
Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance Trait
Cibus, Inc. (CBUS) Q2 2025 Earnings Call Transcript
Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates
Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025
Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call
The U.S. Food and Drug Administration Completes Review of Cibus' Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering
Cibus, Inc. Announces Proposed Public Offering
Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat
Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase
Cibus, Inc. (CBUS) Q1 2025 Earnings Call Transcript
Cibus (CBUS) Reports Q1 Loss, Misses Revenue Estimates
Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025
Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding
Cibus (CBUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release